6505--Sevelamer Carbonate Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the NAC PHARMACEUTICALS office, has issued a Solicitation (36E79726R0023) for Sevelamer Carbonate 800mg Tablets. This is an unrestricted procurement seeking an uninterrupted source of supply for VA, DoD, BOP, IHS, and FHCC. Proposals are due by June 2, 2026, at 2:30 PM CT.
Purpose & Scope
This solicitation aims to establish VA National Contract prices for Sevelamer Carbonate 800mg Tablets, 270 tablets per bottle (Unit of Use), to be distributed through the VA and DoD Pharmaceutical Prime Vendor (PPV) Programs. The objective is to ensure nationwide product availability and consistency with volume-based pricing. The estimated annual usage is 42,891 bottles.
Key Requirements / Deliverables
- Product: Sevelamer Carbonate 800mg Tablets, 270 Tablets per Bottle (Unit of Use).
- Packaging: Unit of use bottles must feature a safety cap (convertible to non-safety), a minimum 120cc volume, a cylindrical body with a 5.75” circumference, and accommodate a 5.25” x 2” label with an additional 0.5” for barcode/expiration/lot number.
- Labeling: Offerors must provide a unique 11-digit National Drug Code (NDC). Bar code labeling (GS1-128 or HIBCC) is required at the unit-of-use package level.
- Compliance: Products must meet FDA cGMP standards and comply with Drug Supply Chain Security Act (DSCSA) requirements for serialized transaction information.
- Manufacturer: Non-manufacturing offerors must submit a Letter of Commitment from the manufacturer.
Contract Details
- Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.
- Period of Performance: One base year plus four pre-priced one-year option periods.
- Distribution: Through Government Prime Vendor contract(s) for VA and DoD.
Submission & Evaluation
- Submission: Proposals must be submitted via email to Matthew.Poulin@va.gov and Teresa.Hussain@va.gov as Microsoft Word or PDF files, including a scanned PDF of the signed SF-1449. Faxed proposals are not accepted.
- Pricing: Offerors must submit prices for the base year and all four option years for line item 1, not exceeding two decimal places, and including a 0.5% Cost Recovery Fee.
- Evaluation: Award will be made to the responsible offeror with the lowest price technically acceptable (LPTA) offer. Technical acceptability includes meeting product descriptions, FDA approval, FDA cGMP compliance, and verifiable manufacturing facility clearance.
- Deadline: Offers are due by June 2, 2026, at 2:30 PM Central Time.
Eligibility / Notes
- This acquisition is unrestricted.
- Offerors must maintain a current and accurate record in the System for Award Management (SAM).
- Subcontracting plans are required for contracts over $900,000 if the offeror is not a small business.
- Offerors must acknowledge any amendments. Attachments A and B list the VA and DoD Pharmaceutical Prime Vendor Contractors.